diagnostic
Innopsys
InnoNews LXRepair RADX

LXRepair diagnostic test RAD-LX

Carbonne - France
20/06/2018

To predict radiotherapy adverse effects

Innopsys and LXRepair entered an agreement in the context of the development of LXRepair diagnostic test RAD-LX™.

RAD-LX™ is intended to predict radiotherapy adverse effects in patients receiving radiotherapy. LXRepair clinical proof of concept study is conducted on 300 patients in collaboration with Pr N. Magné from Institut de Cancérologie Lucien Neuwirth and is almost completed.

LXRepair will use InnoScan scanner.

SIÈGE SOCIAL

Parc d'activités Activestre
31390 Carbonne - FRANCE

CONTACT

Tél. +33 561 971 974
Fax +33 561 971 975